Anti-CTLA4 monoclonal antibodies and chimeric antigen receptors
US-12595307-B2 · Apr 7, 2026 · US
Nantbio Inc holds 143 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 143 |
| Recent patents | 62 |
| First publication | May 24, 2018 |
| Latest publication | Apr 7, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12595307-B2 · Apr 7, 2026 · US
US-2026062714-A1 · Mar 5, 2026 · US
US-12545928-B2 · Feb 10, 2026 · US
US-12516093-B2 · Jan 6, 2026 · US
US-12502404-B1 · Dec 23, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12595307-B2 · Apr 7, 2026 · US
US-2026062714-A1 · Mar 5, 2026 · US
US-12545928-B2 · Feb 10, 2026 · US
US-12516093-B2 · Jan 6, 2026 · US
US-12502404-B1 · Dec 23, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 51 |
| C07K2317/622 | 33 |
| A61K45/06 | 32 |
| C12N15/86 | 32 |
| C12N2710/10343 | 26 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 121 |
| Human Necessities | 101 |
| Physics | 34 |
| Cross-Sectional Technologies | 3 |
| Operations & Transport | 2 |
Answers are generated from the same data shown on this page.